NO964072D0 - Tetrahydronaftofuran- og indanofuranaminforbindelser, fremgangsmåte ved fremstilling derav og farmasöytiske sammensetninger inneholdende dem - Google Patents

Tetrahydronaftofuran- og indanofuranaminforbindelser, fremgangsmåte ved fremstilling derav og farmasöytiske sammensetninger inneholdende dem

Info

Publication number
NO964072D0
NO964072D0 NO964072A NO964072A NO964072D0 NO 964072 D0 NO964072 D0 NO 964072D0 NO 964072 A NO964072 A NO 964072A NO 964072 A NO964072 A NO 964072A NO 964072 D0 NO964072 D0 NO 964072D0
Authority
NO
Norway
Prior art keywords
tetrahydronaphthofuran
indanofuranamine
compounds
preparation
methods
Prior art date
Application number
NO964072A
Other languages
English (en)
Other versions
NO314501B1 (no
NO964072L (no
Inventor
Jean-Louis Peglion
Joel Vian
Aimee Dessinges
Mark Millan
Valerie Audinot
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of NO964072D0 publication Critical patent/NO964072D0/no
Publication of NO964072L publication Critical patent/NO964072L/no
Publication of NO314501B1 publication Critical patent/NO314501B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/92—Naphthofurans; Hydrogenated naphthofurans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO19964072A 1995-09-29 1996-09-27 Tetrahydronaftofuranaminforbindelser, fremgangsmåte ved fremstilling deravog farmasöytiske sammensetninger inneholdende dem NO314501B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9511446A FR2739379B1 (fr) 1995-09-29 1995-09-29 Nouveaux composes amines de 5,6,7,8-tetrahydronaphto(2,3-b) furane et d'indano(5,6-b)furane, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent

Publications (3)

Publication Number Publication Date
NO964072D0 true NO964072D0 (no) 1996-09-27
NO964072L NO964072L (no) 1997-04-01
NO314501B1 NO314501B1 (no) 2003-03-31

Family

ID=9483043

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19964072A NO314501B1 (no) 1995-09-29 1996-09-27 Tetrahydronaftofuranaminforbindelser, fremgangsmåte ved fremstilling deravog farmasöytiske sammensetninger inneholdende dem

Country Status (15)

Country Link
US (1) US5665765A (no)
EP (1) EP0765877B1 (no)
JP (1) JPH09110855A (no)
CN (1) CN1075067C (no)
AT (1) ATE256675T1 (no)
AU (1) AU707883B2 (no)
CA (1) CA2186337C (no)
DE (1) DE69631104T2 (no)
DK (1) DK0765877T3 (no)
ES (1) ES2213171T3 (no)
FR (1) FR2739379B1 (no)
NO (1) NO314501B1 (no)
NZ (1) NZ299465A (no)
PT (1) PT765877E (no)
ZA (1) ZA968167B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7216866B2 (en) * 2003-04-28 2007-05-15 Kyocera Mita Corporation Sheet transport path switching mechanism

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4470990A (en) * 1983-03-14 1984-09-11 Ayerst, Mckenna & Harrison Inc. 6,7,8,9-Tetrahydronaphtho(1,2-B)furan-8-amine derivatives and their use as dopamine receptor stimulants
FR2613365B1 (fr) * 1987-04-01 1989-07-28 Adir Nouveaux derives de l'amino tetrahydro-5, 6, 7, 8 naphto (2, 3b) furanne, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
FR2613364B1 (fr) * 1987-04-01 1989-06-09 Adir Nouvelles amines tricycliques derivees du tetrahydro-5, 6, 7, 8 naphto (2, 3b) dihydro-2, 3 furanne, et du tetrahydro-6, 7, 8, 9 5h-benzocyclohepta (2, 3b) dihydro-2, 3 furanne, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
FR2725985B1 (fr) * 1994-10-21 1996-11-15 Adir Nouveaux composes tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
CA2186337C (fr) 2002-01-01
CN1150151A (zh) 1997-05-21
NZ299465A (en) 1997-06-24
DE69631104D1 (de) 2004-01-29
AU707883B2 (en) 1999-07-22
ATE256675T1 (de) 2004-01-15
NO314501B1 (no) 2003-03-31
CA2186337A1 (fr) 1997-03-30
CN1075067C (zh) 2001-11-21
AU6589796A (en) 1997-04-10
JPH09110855A (ja) 1997-04-28
ZA968167B (en) 1997-05-02
EP0765877A1 (fr) 1997-04-02
EP0765877B1 (fr) 2003-12-17
DK0765877T3 (da) 2004-04-19
DE69631104T2 (de) 2004-09-02
NO964072L (no) 1997-04-01
ES2213171T3 (es) 2004-08-16
FR2739379A1 (fr) 1997-04-04
FR2739379B1 (fr) 1997-10-24
PT765877E (pt) 2004-04-30
US5665765A (en) 1997-09-09

Similar Documents

Publication Publication Date Title
DK0562956T3 (da) Hidtil ukendte naphthylalkylaminer, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
MX9203150A (es) Nuevos esteres de acidos tienilcarboxilicos de aminoalcoholes, sus productos de cuaternizacion y las composiciones farmaceuticas que los contienen.
SE8902326L (sv) Karboxamidfoereningar, foerfaranden foer framstaellning av dem och farmceutiska kompositioner som innehaaller dem
ES2108772T3 (es) Derivados de aminofosfonato substituidos, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ES2142030T3 (es) Nuevos compuestos espiro-heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
DK0423697T3 (da) Lipidemulsion indeholdende en prostaglandinanalog
DK0456209T3 (da) Bis(alkylsubstituerede-4-hydroxyphenylthio)alkananaloger som inhibitorer af kataraktdannelse
DK0553016T3 (da) Hidtil ukendte naphtalenamider og -sulfonamider, fremgangsmåder til deres fremstilling samt farmaceutiske midler indeholdende dem
ES2151155T3 (es) Nuevos taxoides, su preparacion y las composiciones farmaceuticas que les contienen.
DK0605474T3 (da) Carbamatanaloger af thiaphysovenin, farmaceutiske præparater og fremgangsmåder til inhibering af cholinesteraser
NO964072D0 (no) Tetrahydronaftofuran- og indanofuranaminforbindelser, fremgangsmåte ved fremstilling derav og farmasöytiske sammensetninger inneholdende dem
ES2172023T3 (es) Nuevos derivados tetrahidro-piridinicos sustituidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ITMI911853A1 (it) Sale del diclofenac, metodo di preparazione e composizioni farmaceutiche che lo contengono.
ES2077473T3 (es) Nuevos compuestos tiocromanicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
FR2760014B1 (fr) Nouveaux composes de 2-amino indane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DE3567201D1 (en) Derivatives of 3-phenyl-2-propenamine, their preparation and medicines containing them
FR2713644B1 (fr) Nouveaux analogues de l'éburnane, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
DK0596326T3 (da) Aryliden-1-azacycloalkaner og arylalkyl-1-azacycloalkaner og salte deraf, lægemidler indeholdende forbindelserne og forbindelsernes anvendelse samt fremgangsmåde til fremstilling af forbindelserne
ES2061712T3 (es) Nuevos derivados sustituidos de 20,21-dinoreburnamenina, su procedimiento de preparacion y los nuevos productos intermedios asi obtenidos, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen.
ES2065192T3 (es) Nuevos nicotinatos de diacil-glicerol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2095714T3 (es) Nuevas amino-alquil-cromonas, sus procedimientos de preparacion y las composiciones farmaceuticas que las contienen.
ATE191458T1 (de) Benzol-derivate
ES2132429T3 (es) Disacaridos de antraciclina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
BR9101973A (pt) Compostos quimicos,processo para a sua preparacao e composicoes farmaceutica e terapeutica
MX9300136A (es) Alfa-aril-alfa-hidroxi-beta-imidazolinil-propionamidas, procedimiento para su obtencion y medicamentos que las contienen.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees